Exonate is an early stage biopharmaceutical company focused on drug discovery programs in ophthalmology, oncology, and pain. Our lead program targets the development of novel therapies for wet age-related macular degeneration.
Headquarters:
United Kingdom of Great Britain and Northern Ireland
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2013 (12 years)
Address:
WTL MOORFIELD ROAD; DUXFORD, CAMBRIDGESHIRE CB22 4PS, GB
At a glanceLOW
spending power
